CP 55,940 is a cannabinoid which mimics the effects of naturally occurring THC (one of the psychoactive compounds found in cannabis). CP 55,940 was created by Pfizer in 1974 but was never marketed. It is currently used to study the endocannabinoid system.
IUPAC name: 2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl) cyclohexyl]-5-(2-methyloctan-2-yl)phenol
CAS number: 83002-04-4
Purity: 99% min
Appearance: white powder.
The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications.